Forma Therapeutics Holdings FMTX

$ 20.01 0.0%

Quarterly report 2022-Q2
added 12-23-2023

Forma Therapeutics Holdings Income Statement 2011-2024 | FMTX

Annual Income Statement Forma Therapeutics Holdings

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	467 M	890 M	51 M	-	-	-	-	-	-	-	-
Shares	47.3 M	23.1 M	2.55 M	-	-	-	-	-	-	-	-
Historical Prices	9.86	38.6	-	-	-	-	-	-	-	-	-
Net Income	-173 M	-70.4 M	-24.7 M	5.29 M	-	-	-	-	-	-	-
Revenue	-	-	101 M	164 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-174 M	-124 M	-26 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-172 M	-123 M	-23.4 M	13.2 M	-	-	-	-	-	-	-
Operating Expenses	174 M	124 M	136 M	154 M	-	-	-	-	-	-	-
General and Administrative Expenses	48.3 M	30.8 M	24.4 M	21.5 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Forma Therapeutics Holdings

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	47.8 M	47.8 M	47.4 M	47.4 M	47.3 M	47.3 M	47.2 M	41.1 M	5.94 M	2.55 M	2.25 M	-	2.55 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-52.6 M	-44.2 M	-	-43.3 M	-43.6 M	-36 M	-28.6 M	-27.6 M	-25.4 M	11.2 M	-24.7 M	-31 M	-14.8 M	35.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	7.44 M	3.38 M	17.7 M	72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-53 M	-44.4 M	-	-43.4 M	-44.1 M	-36.2 M	-32.8 M	-32.2 M	-26.9 M	-32.2 M	-26 M	-31.8 M	-16.9 M	34.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-53 M	-43.8 M	-	-43.1 M	-43.9 M	-36 M	-32.8 M	-31.9 M	-26.6 M	-31.7 M	-26 M	-31.2 M	-16.3 M	34.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	44.4 M	-	43.4 M	44.1 M	36.2 M	32.8 M	32.2 M	26.9 M	32.2 M	33.5 M	35.1 M	34.6 M	37.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	13.1 M	-	12.7 M	12.5 M	9.87 M	7.94 M	7.46 M	6.45 M	8.93 M	6.77 M	7.02 M	5.69 M	4.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency